India’s fast-growing healthtech ecosystem continues to attract investor confidence as neurotechnology startup Mave Health has secured $2.1 million (around ₹18 crore) in a seed funding round led by Blume Ventures. The round also witnessed participation from a strong mix of global and domestic investors including Inuka Capital, Stanford Angels, founders of Groww, Aureolis Ventures, Raymond Russell, and Juhi Bhatnagar of Forj Capital. Existing backer All In Capital also doubled down on its investment, signalling continued belief in the startup’s long-term potential.
Strengthening Mental Health Through Technology
Founded with a vision to transform mental healthcare in India, Mave Health is building solutions at the intersection of neuroscience, wearable technology, and personalised care. The startup focuses on tackling conditions such as depression using non-invasive neurotechnology combined with expert-led wellness programs.
Its flagship offering revolves around a brain stimulation wearable designed to improve mental well-being through structured therapy programs. Unlike traditional reactive approaches to mental health, Mave Health aims to provide proactive, evidence-based solutions that integrate technology with continuous human support.
The fresh capital will help the company enhance its product capabilities, scale its technology infrastructure, and expand its reach across India. It is also expected to support hiring across research, product development, and clinical expertise as demand for digital mental health solutions continues to rise.
Building on Previous Funding Momentum
This latest round comes after Mave Health previously raised around $750,000 in a pre-seed round in November 2023, indicating steady investor interest in the startup’s growth journey.
The company has shown early traction in India’s evolving mental health market, where awareness is increasing but access to quality care remains limited. By combining neuroscience-backed tools with personalised programs, Mave Health is positioning itself as a differentiated player in the space.
Investor Confidence in India’s Healthtech Boom
Blume Ventures’ investment aligns with its broader strategy of backing early-stage startups solving large-scale problems through technology. The firm has been actively investing in healthtech, fintech, and deeptech startups through its latest fund, reflecting confidence in India’s innovation ecosystem.
The funding also highlights a larger trend where investors are increasingly focusing on mental health startups, especially those leveraging advanced technologies like AI and neurotech to deliver scalable solutions.
The Road Ahead
With rising stress levels, urban lifestyle challenges, and growing awareness around mental well-being, India’s mental health market is poised for significant growth. Startups like Mave Health are attempting to bridge the gap between clinical care and accessible everyday solutions.
As the company scales its offerings and expands its footprint, it will play a key role in redefining how mental health is approached in India—moving from stigma-driven silence to technology-enabled care.